OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
HVT.HN56

Viet Tri Chemical JSC

Commodity ChemicalsVerified

Viet Tri Chemical JSC maintains a debt-to-equity ratio of 0.56, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is assessed as medium, with a current ratio of 0.91, suggesting that its current liabilities slightly exceed its current assets. Free cash flow is negative at -12,074.63 billion VND, primarily due to significant capital expenditures of -78,395.41 billion VND, which outpace operating cash flow of 36,888.79 billion VND. Profitability metrics show a return on equity (ROE) of 4.19% and a return on assets (ROA) of 2.06%, both below the industry median for Commodity Chemicals. This suggests that the company is underperforming in terms of capital efficiency and asset utilization compared to its peers. Gross profit of 68,753.97 billion VND and operating income of 20,745.98 billion VND indicate a relatively narrow margin structure, which may be sensitive to input cost fluctuations and pricing pressures. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks, particularly in the Vietnamese market. No material revenue is attributed to international operations, and the company does not report segment-specific performance metrics. Looking ahead, the company's growth trajectory is constrained by its capital structure and operational cash flow dynamics. With a negative free cash flow and high capital expenditures, the company is unlikely to increase dividends or repurchase shares in the near term. Revenue growth is expected to remain modest, with no disclosed expansion plans or new product launches in the latest filings. Risk factors include liquidity constraints and the potential for dilution, though the latter is currently assessed as low. The company's net cash position is negative after subtracting total debt, which could limit its ability to fund operations or invest in growth without external financing. No recent equity offerings or dilutive events have been reported, and the number of shares outstanding remains unchanged between basic and diluted shares. Recent events include the publication of the latest financial report, which highlights the company's continued focus on cost control and operational efficiency. No material legal or regulatory actions have been disclosed, and the company has not issued any forward-looking guidance for the current or next fiscal year.

30-day price · HVT.HN-100.00 (-0.4%)
Low$27000.00High$28500.00Close$27400.00As of15 May, 00:00 UTC
Profile
CompanyViet Tri Chemical JSC
TickerHVT.HN
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Viet Tri Chemical JSC is a chemical manufacturing company in Vietnam, primarily engaged in the production and distribution of commodity chemicals, with revenue derived from the sale of chemical products to industrial and consumer markets.

Classification. Viet Tri Chemical JSC is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Viet Tri Chemical JSC maintains a debt-to-equity ratio of 0.56, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is assessed as medium, with a current ratio of 0.91, suggesting that its current liabilities slightly exceed its current assets. Free cash flow is negative at -12,074.63 billion VND, primarily due to significant capital expenditures of -78,395.41 billion VND, which outpace operating cash flow of 36,888.79 billion VND. Profitability metrics show a return on equity (ROE) of 4.19% and a return on assets (ROA) of 2.06%, both below the industry median for Commodity Chemicals. This suggests that the company is underperforming in terms of capital efficiency and asset utilization compared to its peers. Gross profit of 68,753.97 billion VND and operating income of 20,745.98 billion VND indicate a relatively narrow margin structure, which may be sensitive to input cost fluctuations and pricing pressures. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks, particularly in the Vietnamese market. No material revenue is attributed to international operations, and the company does not report segment-specific performance metrics. Looking ahead, the company's growth trajectory is constrained by its capital structure and operational cash flow dynamics. With a negative free cash flow and high capital expenditures, the company is unlikely to increase dividends or repurchase shares in the near term. Revenue growth is expected to remain modest, with no disclosed expansion plans or new product launches in the latest filings. Risk factors include liquidity constraints and the potential for dilution, though the latter is currently assessed as low. The company's net cash position is negative after subtracting total debt, which could limit its ability to fund operations or invest in growth without external financing. No recent equity offerings or dilutive events have been reported, and the number of shares outstanding remains unchanged between basic and diluted shares. Recent events include the publication of the latest financial report, which highlights the company's continued focus on cost control and operational efficiency. No material legal or regulatory actions have been disclosed, and the company has not issued any forward-looking guidance for the current or next fiscal year.
Key takeaways
  • Viet Tri Chemical JSC operates in the Commodity Chemicals industry with a moderate debt load and limited liquidity.
  • The company's ROE and ROA are below industry medians, indicating suboptimal capital and asset utilization.
  • Revenue is concentrated in a single segment and geographic region, increasing exposure to local economic and regulatory risks.
  • Negative free cash flow and high capital expenditures constrain the company's ability to return value to shareholders.
  • Dilution risk is currently low, but liquidity constraints could necessitate external financing in the near term.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyVND
Revenue$361.87B
Gross profit$68.75B
Operating income$20.75B
Net income$16.71B
R&D
SG&A
D&A
SBC
Operating cash flow$36.89B
CapEx-$78.40B
Free cash flow-$12.07B
Total assets$811.73B
Total liabilities$413.22B
Total equity$398.52B
Cash & equivalents
Long-term debt$222.82B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$818.69B
FY-3$1.38T$217.72B$177.01B$152.98B
FY-2$1.26T$82.81B$67.66B-$199.34B
FY-1$1.45T$106.49B$84.74B$25.89B
FY0$1.60T$124.34B$98.84B$118.52B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$283.62B$5.25B
FY-3$688.40B$437.18B$25.00B
FY-2$754.64B$398.93B$0.00
FY-1$844.73B$456.11B
FY0$841.04B$504.90B$35.00B
PeriodOCFCapExFCFSBC
FY-4$67.88B-$41.46B
FY-3$99.06B-$59.59B$152.98B
FY-2$179.54B-$248.40B-$199.34B
FY-1$70.32B-$105.03B$25.89B
FY0$151.19B-$25.13B$118.52B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$361.87B$20.75B$16.71B-$12.07B
FQ-6$378.41B$33.81B$26.78B-$80.21B
FQ-5$368.89B$38.17B$30.82B$131.83B
FQ-4$392.42B$20.08B$16.20B$36.98B
FQ-3$381.84B$30.40B$24.42B-$22.06B
FQ-2$421.98B$40.61B$31.96B$60.22B
FQ-1$407.14B$33.25B$26.26B$43.38B
FQ0$419.77B$38.47B$30.91B$39.84B
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$811.73B$398.52B
FQ-6$769.16B$425.29B
FQ-5$844.73B$456.11B
FQ-4$876.97B$472.31B
FQ-3$817.58B$446.67B
FQ-2$821.17B$478.63B
FQ-1$841.04B$504.90B$35.00B
FQ0$829.15B$535.80B$0.00
PeriodOCFCapExFCFSBC
FQ-7$36.89B-$78.40B-$12.07B
FQ-6$202.77B-$185.99B-$80.21B
FQ-5$70.32B-$105.03B$131.83B
FQ-4$67.27B-$1.48B$36.98B
FQ-3$67.24B-$28.25B-$22.06B
FQ-2$132.48B-$21.16B$60.22B
FQ-1$151.19B-$25.13B$43.38B
FQ0$49.61B-$8.12B$39.84B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$398.52B
Net cash-$222.82B
Current ratio0.9
Debt/Equity0.6
ROA2.1%
ROE4.2%
Cash conversion2.2%
CapEx/Revenue-21.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricHVT.HNActivity
Op margin5.7%5.5% medp25 -0.0% · p75 10.8%above median
Net margin4.6%4.1% medp25 0.1% · p75 8.8%above median
Gross margin19.0%20.5% medp25 12.4% · p75 29.7%below median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-21.7%-6.2% medp25 -13.4% · p75 -2.6%bottom quartile
Debt / equity56.0%37.1% medp25 10.3% · p75 82.0%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 03:23 UTC#5db5eb64
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 04:06 UTCJob: 04ec32ce